Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

ClinicalTrials.gov ID: NCT04052425

Public ClinicalTrials.gov record NCT04052425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1): A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adolescent and adult participants with non-segmental vitiligo for whom total body involved vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).

Study identification

NCT ID
NCT04052425
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
330 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 19, 2019
Primary completion
Mar 17, 2021
Completion
Oct 20, 2021
Last update posted
Aug 21, 2025

2019 – 2021

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Cahaba Dermatology Hoover Alabama 35244
Cognitive Clinical Trials Scottsdale Btc Ppds Scottsdale Arizona 85260
Burke Pharmaceutical Research Hot Springs Arkansas 71913
First Oc Dermatology Fountain Valley California 92708
Marvel Clinical Research Llc Huntington Beach California 92647
Rady Children'S Hospital - San Diego San Diego California 92123
University of California San Francisco Sub Location San Francisco California 94158
Clinical Research Center of Ct Danbury Connecticut 06810
Harmony Medical Research Institute Hialeah Florida 33016
San Marcus Research Clinic Inc. Miami Lakes Florida 33014
ForCare Medical Center Tampa Florida 33613
Forcare Clinical Research Fcr Forward Clinical Trials, Inc Tampa Florida 33624
Metabolic Research Institute Inc West Palm Beach Florida 33401
Northwestern University Chicago Illinois 60611
Clinical Trials Management Llc Metairie Louisiana 70006
Great Lakes Research Group Inc Bay City Michigan 48706
Dermatology Specialists of Brighton Brighton Michigan 48114
Suny Downstate Medical Center Brooklyn New York 11203
Forest Hills Dermatology Group Forest Hills New York 11375
The Dermatology Specialists Greenwich New York New York 10012
Wake Research Associates Llc Raleigh North Carolina 27612
Wake Forest University Winston-Salem North Carolina 27157
Kgl Skin Study Center Broomall Pennsylvania 19008
Dermatology Associates of Plymouth Meeting Plymouth Meeting Pennsylvania 19462
Palmetto Clinical Trial Services Anderson South Carolina 29621
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130
Progressive Clinical Research San Antonio Texas 78213
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229
Dermatology Specialists of Spokane Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04052425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2025 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04052425 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →